IP Library Patent Application 10722737
Patent Application
App. No. 10/722,737

Compositions and methods for treating neuropathic sensory loss

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
10/722,737
Abstract

The present invention relates to methods of reducing the effects of neuropathically induced negative sensory phenomena (NSP). NSP are manifested as the decreased ability to feel light touch, pain, proprioception, vibration, warmth/heat, and coolness/cold. The NSP are treated by application of an anesthetic. The anesthetic is preferably a benzoic acid-based anesthetic. Specifically, a patch containing about 5% lidocaine may be used. The anesthetic is transdermally administered to a patient suffering from NSP at or near the locus of the negative sensory phenomena.

Claims (11)

1 . A method for treating neuropathic negative sensory phenomena comprising applying an anesthetic to a patient suffering from neuropathic negative sensory phenomena at or near the locus of the negative sensory phenomena.

2 . The method of claim 1 wherein said anesthetic is a benzoic acid derivative.

3 . The method of claim 2 , wherein said benzoic acid derivative is selected from the group consisting of benzocaine, procaine, tetracaine, chloroprocaine, propoxycaine, cocaine, proparacaine, mepivacaine, bupivacaine, phenocaine, dibucaine, etidocaine, lidocaine, prilocalne, and pharmaceutically acceptable salts thereof.

4 . The method of claim 3 , wherein the benzoic acid derivative is lidocaine.

5 . The method of claim 4 , wherein the lidocaine is contained in a patch.

6 . The method of claim 5 , wherein said patch contains between about 2% and about 10% lidocaine.

7 . The method of claim 6 , wherein said patch contains about 5% lidocaine.

8 . A method according to claim 1 , wherein method further comprises applying a cover over said anesthetic, said cover formed from a material selected from the group consisting of polyvinyl chloride, polyvinylidene chloride, polyethylene, synthetic rubber, woven polyester fabric, and non-woven polyester fabric.

9 . A method for treating neuropathic negative sensory phenomena by transdermal administration of an anesthetic, said method comprising: applying a non-woven polyester cloth including a physiologically acceptable adhesive, comprising from about 2 to 10% by weight of lidocaine, at or near the locus of the negative sensory phenomena.

10 . A method according to claim 9 , wherein said lidocaine is present in about 5% by weight.

11 . A method for decreasing numbness of the skin of a patient comprising applying a local anesthetic to said skin at or near a site of said numbness.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ENDO PHARMACEUTICALS, INC.; ENDO PHARMACEUTICALS SOLUTIONS, INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
Reel/Frame 042362/0001 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 032380/0198 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL/FRAME 25416/381 Recorded Jul 11, 2011
From: JPMORGAN CHASE BANK N.A., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 026572/0148 →
SECURITY AGREEMENT Recorded Jul 7, 2011
From: ENDO PHARMACEUTICALS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026557/0350 →
RELEASE OF PATENT SECURITY INTEREST RECORDED AT REEL/FRAME 23390/120 Recorded Dec 3, 2010
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 025441/0305 →
SECURITY AGREEMENT Recorded Dec 1, 2010
From: ENDO PHARMACEUTICALS INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 025416/0381 →
SECURITY AGREEMENT Recorded Oct 19, 2009
From: ENDO PHARMACEUTICALS INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 023390/0120 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 8, 2004
From: GALER, BRADLEY S.; GAMMAITONI, ARNOLD R.; DWORKIN, ROBERT H.
To: ENDO PHARMACEUTICALS INC.
Reel/Frame 015347/0900 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 15, 2004
From: GALER, BRADLEY S.
To: ENDO PHAMRACEUTICALS INC.
Reel/Frame 015069/0821 →